Book Review: “No Time Marketing” Can Help Startups Start Their PR & Marketing Campaigns
M2 Pharma: “Akston Biosciences collaborates with LakePharma to develop commercial quantities of Akston’s COVID-19 vaccine candidate”
Canton Community TV: “In the Spotlight-Alegria Cohen on Malnutrition in Seniors”
Canton Citizen: “Canton residents awarded scholarships from Hebrew SeniorLife communities”
The Late Late Show with James Corden: “A Company in Massachusetts has created a new type of tattoo ink”
RepublicWorld.com (India): “Akston Biosciences Launches Phase I/II Clinical Trial Of Second-Generation COVID-19 Vaccine: Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first participants have been dosed in an open-label trial of AKS-452, its COVID-19 vaccine candidate”
Do We Still Need General-Interest Newsweeklies?
Once Competitors, Local TV Stations Are Sharing Resources
PitchBook: “Eurazeo to sell pharma company Seqens”
Drug Discovery & Development on Twitter: “An inexpensive investigational #Vaccine is stable for weeks at room temperature & can potentially be used for both prime & boost #Vaccination. Developer Akston #Biosciences, has hooked up with @LakePharma to #Manufacture it https://drugdiscoverytrends.com/akston-biosciences-and-lakepharma-team-up-on-second-generation-covid-19-vaccine/… #ClinicalTrials @researchumcg”
Dell’s Blog Campaign Clicks In
Canadian Manufacturing: “Vortex International names Sylvain Dugas as new COO:Dugas will be responsible for the company’s operations with a focus on optimizing operational efficiency and organizational capability as Vortex continues to grow”